MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53-Reference-Cited by-同舟云学术

MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53

Published:2016-01 Issue:1 Volume:61 Page:68-83
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Wienken Magdalena,Dickmanns Antje,Nemajerova Alice,Kramer Daniela,Najafova Zeynab,Weiss Miriam,Karpiuk Oleksandra,Kassem Moustapha,Zhang Yanping,Lozano Guillermina,Johnsen Steven A.,Moll Ute M.,Zhang Xin,Dobbelstein Matthias

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference82 articles.

1. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression;Abdel-Wahab;Cancer Cell,2012

2. High-frequency developmental abnormalities in p53-deficient mice;Armstrong;Curr. Biol.,1995

3. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity;Ben-Saadon;Mol. Cell,2006

4. TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein;Bhatnagar;Nature,2014

5. Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation;Blackledge;Cell,2014

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ribosomal protein L22 binds the MDM4 pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress;Cell Reports;2024-08

2. A CRISPR/Cas9 screen in embryonic stem cells reveals that Mdm2 regulates totipotency exit;Communications Biology;2024-07-03

3. Single-cell transcriptomics reveals the intra-tumoral heterogeneity and SQSTM1/P62 and Wnt/β-catenin mediated epithelial to mesenchymal transition and stemness of triple-negative breast cancer;Experimental Cell Research;2024-05

4. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma;Clinical Epigenetics;2024-04-10

5. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15